Romania: the drug agency announced restrictions related to COVID-19*
1405
post-template-default,single,single-post,postid-1405,single-format-standard,bridge-core-3.3.2,cookies-not-set,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-smooth-scroll-enabled,qode-child-theme-ver-1.0.0,qode-theme-ver-30.8.2,qode-theme-bridge,wpb-js-composer js-comp-ver-7.9,vc_responsive

Romania: the drug agency announced restrictions related to COVID-19*

* This post has been marked as outdated and is available in our archive.

The Romanian ANMDMR (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale din Romania) announced on 12.03.2020 restrictions of the activity of their Registration Department. In view of the current epidemiological context and in order to avoid as much as possible any document related trips and visits, all submissions shall be made via mail service or e-mail. The single point of electronic contact (PCU-e) and CESP (for medicines for human use) are also available. Audiences are suspended as well. The restrictions shall apply until April 15th with the possibility of extensions.